In the face of a debilitating disease, Glenn Rowan's story is a stark reminder of the harsh realities older Australians with motor neurone disease (MND) face. The 78-year-old, battling MND since 2022, has been forced to make a heart-wrenching choice: either deplete his savings to fund 24/7 care or opt for premature euthanasia. This dilemma is not unique to Rowan; it's a growing concern for many Australians diagnosed with MND after turning 65, who are ineligible for the National Disability Insurance Scheme (NDIS) and instead rely on the aged care system.
What makes Rowan's situation particularly poignant is the stark contrast in funding between the NDIS and the aged care system. While those diagnosed with MND before turning 65 can access the NDIS, offering up to $300,000 or more, those diagnosed after 65 are left to navigate the aged care system, which falls short of the necessary funding. The highest Support at Home package at Level 8, offering up to $78,200, is simply insufficient for the 24/7 care required by MND patients. Rowan, for instance, is paying a staggering $7,000 a week out of pocket for disability support.
This disparity in funding is not just a financial burden; it's a matter of dignity and quality of life. The aged care system, designed for aging-related needs, is ill-equipped to handle the severe physical disabilities associated with MND. The paralysis that comes with MND means patients require round-the-clock care, which the current funding levels cannot provide. This leaves families financially crippled, if not bankrupt, as they struggle to meet the escalating costs of care.
The recent announcement of fast-tracked aged care funding for people over 65 diagnosed with MND is a step in the right direction. However, it falls short of addressing the fundamental issue of inadequate funding. The automated assessment tool, which determines aged care package funding levels, often fails to categorize people with MND at the highest funding level, resulting in funding that barely covers basic needs. The lack of price caps regulating the increased cost of at-home care services further exacerbates the problem.
The situation is further complicated by the rapid physical deterioration of MND, which sets it apart from other neurological diseases typically associated with aging. The median age for MND symptoms is 64, and half of Professor Dominic Rowe's patients qualify for the NDIS, while the other half do not. This means that a person diagnosed just one day after turning 65 receives $80,000 in a Level 8 package, while someone diagnosed at 64 receives $300,000. This disparity in funding can lead to difficult decisions, with some patients opting for voluntary assisted dying due to the lack of practical care options in the community.
The call for government action is clear. The consequences of the current system are devastating for patients and their families, and the cost of providing dignity and care in the last part of life is not significant. The government must recognize the unique needs of MND patients and work towards a more equitable and supportive system. The recent acceptance of Rowan's request for voluntary assisted dying highlights the urgency of this issue. It's time for a comprehensive review of the aged care system, one that prioritizes the needs of those with severe disabilities and ensures that no one is left to face the harsh realities of MND alone.
